Skip to main content
Mayinglong Pharmaceutical Group Co.,Ltd logo

Mayinglong Pharmaceutical Group Co.,Ltd — Investor Relations & Filings

Ticker · 600993 ISIN · CNE000001HN2 Shanghai Stock Exchange Manufacturing
Open in API
Filings indexed 931 across all filing types
Latest filing 2005-12-02 Board/Management Inform…
Country CN China
Listing Shanghai Stock Exchange 600993

About Mayinglong Pharmaceutical Group Co.,Ltd

https://www.mayinglong.cn/

Mayinglong Pharmaceutical Group Co.,Ltd. is a long-established enterprise specializing in the research, development, and production of Traditional Chinese Medicine (TCM). Founded in 1582, the company is widely recognized for its expertise in proctology, maintaining a dominant market position with its signature hemorrhoid ointments and suppositories. Its product portfolio also includes ophthalmic preparations, dermatological treatments, and gastrointestinal medicines. The company integrates traditional medicinal formulas with modern manufacturing technologies to provide healthcare solutions. Beyond pharmaceuticals, Mayinglong has expanded into healthcare services, including specialized hospitals and personal care products, focusing on the integration of clinical treatment and health management.

Recent filings

Filing Released Lang Actions
第五届监事会第六次会议决议公告
Board/Management Information Classification · 95% confidence The document is an announcement of a resolution passed by the Supervisory Board (监事会) of Wuhan Mayinglong Pharmaceutical Group Co., Ltd. regarding the establishment of a new logistics company funded partly by proceeds from the company's IPO. It details the meeting date, voting method, and the decision to set up the logistics company to implement a logistics distribution center project. The document is a formal announcement of a board/management decision rather than a full report or financial statement. It does not contain financial data or detailed financial results, nor is it a regulatory filing or a report publication announcement. Therefore, it fits best under Board/Management Information (MANG).
2005-12-02 Chinese
对外投资公告
Capital/Financing Update Classification · 95% confidence The document is an announcement from Wuhan Mayinglong Pharmaceutical Group Co., Ltd. regarding an external investment by its subsidiaries in another pharmaceutical company, Anhui Jingfang Pharmaceutical Co., Ltd. It details the investment amounts, share transfers, and the impact on the company's business. The document includes information about board approval and independent directors' opinions but does not contain financial statements or detailed financial performance data. The length is 2516 characters, which is relatively short and consistent with an announcement rather than a full report. The content focuses on the investment transaction and related agreements, which fits the category of Capital/Financing Update rather than a full Annual Report, Interim Report, or Audit Report. Therefore, the appropriate classification is Capital/Financing Update (CAP).
2005-11-30 Chinese
第五届董事会第十三次会议决议公告
Board/Management Information Classification · 95% confidence The document is an announcement of a board meeting resolution by Wuhan Mayinglong Pharmaceutical Group Co., Ltd. It details the approval of an investment in Anhui Jingfang Pharmaceutical Co., Ltd. through equity transfer and capital increase. The text includes specifics about shareholding percentages and investment amounts. There is no indication that this is a full financial report, audit, or earnings release. It is not a notice of voting results but rather a management or board announcement about a corporate action. The document length is short (764 characters), and it is a formal announcement of a board decision, fitting the category of Board/Management Information (MANG).
2005-11-30 Chinese
股东股权解冻及质押的公告
Major Shareholding Notification Classification · 95% confidence The document is a short announcement regarding the unfreezing and pledge of shareholder shares, including details about the shareholder, the percentage of shares involved, and the pledge to a bank. It is a regulatory announcement about shareholding status changes but does not report financial results, management changes, or capital structure changes. It is not a full report or financial statement. The content fits best with a Major Shareholding Notification (MRQ) as it involves changes in significant share ownership and pledging of shares by a major shareholder.
2005-11-21 Chinese
股东股权冻结公告
Regulatory Filings Classification · 95% confidence The document is a short announcement regarding the freezing of shareholder equity due to a legal dispute and court order. It does not contain financial statements, management discussion, or detailed report content. It is a regulatory announcement about shareholder equity status, fitting best under Regulatory Filings (RNS) as it does not match other specific categories like Annual Report, Earnings Release, or Legal Proceedings Report (which would require more detailed legal case information). The document length is very short (266 characters), and it is an announcement rather than a full report.
2005-11-04 Chinese
第五届董事会第十二次会议决议公告
Board/Management Information Classification · 90% confidence The document is a resolution announcement from the company's board of directors regarding the approval of the third quarter report and other internal rules. It is not the actual quarterly report itself but a board meeting decision notice. The document length is short (370 characters), and it mainly announces the board meeting resolutions, including the review of the third quarter report. This fits best under Board/Management Information (MANG) as it relates to board meeting decisions and internal governance matters rather than the full quarterly report or financial data.
2005-10-19 Chinese

Browse filings by year

23 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.